We believe, and have now demonstrated, that gene therapy is a rational approach for the treatment of rare monogenic diseases in particular—one that allows for the efficient delivery of a ...

Competing Interests: The authors declared no competing interests. Monogenic hypertension is caused by single gene mutations and accounts for a spectrum of familial forms of elevated blood pressure ...